Rosacea. Other rosacea
Conditions
Interventions
Intervention group: Intervention group: The volunteers' faces are divided into two equal parts, right and left, and the intervention area is determined by tossing a coin. The other side is treated wit
and it is emphasized that in case of any irritation, they should stop using the drug until the skin recovers. In the carboxytherapy area, the treatment continues once every two weeks for up to 5 sessi
In addition, if the needle becomes dull, we replace it with a new one. The patient is advised to avoid washing the area for 24 hours after the treatment to prevent edema. Participants are monitored fo
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to No maximum
Inclusion criteria
Inclusion criteria: Patient consent to participate in the study Age>15 Presence of rosacea lesions in the facial area, relatively symmetrical on both sides Both sexes
Exclusion criteria
Exclusion criteria: Absence of medication (including dietary supplements) for 6 weeks prior to study start Avoid simultaneous use of systemic and topical medications to treat rosacea lesions. Absence of connective tissue diseases or genodermatoses Lack of tendency to form keloids No smoking, alcohol, or drug abuse Not pregnant Not breastfeeding Not having any systemic diseases such as diabetes, kidney diseases, heart diseases, respiratory diseases, liver diseases, severe anemia, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Papule assessment: The number of papules is counted at time zero, before each session, and two weeks after the last session and recorded on a special patient information form. Timepoint: Time zero (before the start of the study), before each session, and two weeks after the last session. Method of measurement: Photographing each half of the face.;Pustule assessment: The number of pustules is counted at time zero, before each session, and two weeks after the last session and recorded on a special patient information form. Timepoint: Time zero (before the start of the study), before each session, and two weeks after the last session. Method of measurement: Photographing each half of the face.;Pustule assessment: The number of pustules is counted at time zero, before each session and two weeks after the last session and recorded in a special patient information form. - Erythema assessment: The extent of erythema is assessed at time zero, before each session and two weeks after the last session and recorded in a special patient information form. For this purpose, the scoring system in Table 1 is used. Table 1: Scoring system for erythema assessment (11) 0: Absence of erythema I (mild): Brief erythema, limited to central or generalized involvement of the entire face II (moderate): Intensified erythema limited to the central or generalized involvement of the entire face III (severe): Severe erythema involving the entire face. Timepoint: Time zero (before the start of the study), before each session, and two weeks after the last session. Method of measurement: Photographing each half of the face.;- Telangiectasia assessment: The extent of telangiectasia is assessed at time zero, before each session and two weeks after the last session and recorded in a special patient information form. For this purpose, the scoring system in Table 2 is used .Table 2: Scoring system for assessing telangiectasia(11)0: Absence of telangiectasia I (mild): Fine vessels smaller than 0.2 mm with | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlireza Abaee Hezaveh
Arak University of Medical Sciences
Outcome results
None listed